vs

Side-by-side financial comparison of CABOT CORP (CBT) and Stride, Inc. (LRN). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $629.9M, roughly 1.3× Stride, Inc.). Stride, Inc. runs the higher net margin — 14.1% vs 8.6%, a 5.5% gap on every dollar of revenue. On growth, Stride, Inc. posted the faster year-over-year revenue change (2.7% vs -11.1%). Over the past eight quarters, Stride, Inc.'s revenue compounded faster (8.6% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Stride, Inc. is a for-profit education company that provides online and blended education programs. Stride, Inc. is an education management organization (EMO) that provides online education designed as an alternative to traditional "brick and mortar" education for public school students from kindergarten to 12th grade, as well as career learning programs. As of 2012, publicly traded Stride, Inc. was the largest EMO in terms of enrollment.

CBT vs LRN — Head-to-Head

Bigger by revenue
CBT
CBT
1.3× larger
CBT
$849.0M
$629.9M
LRN
Growing faster (revenue YoY)
LRN
LRN
+13.8% gap
LRN
2.7%
-11.1%
CBT
Higher net margin
LRN
LRN
5.5% more per $
LRN
14.1%
8.6%
CBT
Faster 2-yr revenue CAGR
LRN
LRN
Annualised
LRN
8.6%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CBT
CBT
LRN
LRN
Revenue
$849.0M
$629.9M
Net Profit
$73.0M
$88.5M
Gross Margin
24.9%
Operating Margin
15.2%
20.5%
Net Margin
8.6%
14.1%
Revenue YoY
-11.1%
2.7%
Net Profit YoY
-21.5%
8.5%
EPS (diluted)
$1.37
$1.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
LRN
LRN
Q3 26
$629.9M
Q4 25
$849.0M
$631.3M
Q3 25
$899.0M
$620.9M
Q2 25
$923.0M
$653.6M
Q1 25
$936.0M
$613.4M
Q4 24
$955.0M
$587.2M
Q3 24
$1.0B
$551.1M
Q2 24
$1.0B
$534.2M
Net Profit
CBT
CBT
LRN
LRN
Q3 26
$88.5M
Q4 25
$73.0M
$99.5M
Q3 25
$43.0M
$68.8M
Q2 25
$101.0M
$51.3M
Q1 25
$94.0M
$99.3M
Q4 24
$93.0M
$96.4M
Q3 24
$137.0M
$40.9M
Q2 24
$109.0M
$62.8M
Gross Margin
CBT
CBT
LRN
LRN
Q3 26
Q4 25
24.9%
41.1%
Q3 25
24.5%
39.0%
Q2 25
26.4%
36.6%
Q1 25
25.7%
40.6%
Q4 24
24.6%
40.8%
Q3 24
24.0%
39.2%
Q2 24
25.2%
35.2%
Operating Margin
CBT
CBT
LRN
LRN
Q3 26
20.5%
Q4 25
15.2%
23.3%
Q3 25
15.2%
11.1%
Q2 25
18.1%
8.7%
Q1 25
17.3%
21.3%
Q4 24
16.2%
21.3%
Q3 24
15.0%
8.6%
Q2 24
16.9%
13.8%
Net Margin
CBT
CBT
LRN
LRN
Q3 26
14.1%
Q4 25
8.6%
15.8%
Q3 25
4.8%
11.1%
Q2 25
10.9%
7.9%
Q1 25
10.0%
16.2%
Q4 24
9.7%
16.4%
Q3 24
13.7%
7.4%
Q2 24
10.7%
11.8%
EPS (diluted)
CBT
CBT
LRN
LRN
Q3 26
$1.93
Q4 25
$1.37
$2.12
Q3 25
$0.80
$1.40
Q2 25
$1.86
$0.96
Q1 25
$1.69
$2.02
Q4 24
$1.67
$2.03
Q3 24
$2.41
$0.94
Q2 24
$1.94
$1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
LRN
LRN
Cash + ST InvestmentsLiquidity on hand
$230.0M
$614.0M
Total DebtLower is stronger
$417.6M
Stockholders' EquityBook value
$1.6B
$1.6B
Total Assets
$3.8B
$2.4B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
LRN
LRN
Q3 26
$614.0M
Q4 25
$230.0M
$625.7M
Q3 25
$258.0M
$715.1M
Q2 25
$239.0M
$985.3M
Q1 25
$213.0M
$723.7M
Q4 24
$183.0M
$717.5M
Q3 24
$223.0M
$522.2M
Q2 24
$197.0M
$692.3M
Total Debt
CBT
CBT
LRN
LRN
Q3 26
$417.6M
Q4 25
$417.2M
Q3 25
$1.1B
$416.8M
Q2 25
$416.3M
Q1 25
$415.9M
Q4 24
$415.5M
Q3 24
$1.1B
$415.1M
Q2 24
$414.7M
Stockholders' Equity
CBT
CBT
LRN
LRN
Q3 26
$1.6B
Q4 25
$1.6B
$1.5B
Q3 25
$1.6B
$1.5B
Q2 25
$1.5B
$1.5B
Q1 25
$1.4B
$1.4B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.2B
Q2 24
$1.3B
$1.2B
Total Assets
CBT
CBT
LRN
LRN
Q3 26
$2.4B
Q4 25
$3.8B
$2.3B
Q3 25
$3.8B
$2.3B
Q2 25
$3.8B
$2.3B
Q1 25
$3.8B
$2.2B
Q4 24
$3.6B
$2.1B
Q3 24
$3.7B
$2.0B
Q2 24
$3.6B
$1.9B
Debt / Equity
CBT
CBT
LRN
LRN
Q3 26
0.25×
Q4 25
0.27×
Q3 25
0.70×
0.27×
Q2 25
0.28×
Q1 25
0.29×
Q4 24
0.32×
Q3 24
0.75×
0.34×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
LRN
LRN
Operating Cash FlowLast quarter
$126.0M
$117.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
1.32×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
LRN
LRN
Q3 26
$117.0M
Q4 25
$126.0M
$91.8M
Q3 25
$219.0M
$-195.8M
Q2 25
$249.0M
$298.3M
Q1 25
$73.0M
$53.1M
Q4 24
$124.0M
$223.4M
Q3 24
$204.0M
$-142.0M
Q2 24
$207.0M
$172.2M
Free Cash Flow
CBT
CBT
LRN
LRN
Q3 26
Q4 25
$57.0M
$91.6M
Q3 25
$155.0M
$-196.1M
Q2 25
$188.0M
$297.9M
Q1 25
$1.0M
$52.9M
Q4 24
$47.0M
$222.9M
Q3 24
$112.0M
$-142.7M
Q2 24
$155.0M
$171.4M
FCF Margin
CBT
CBT
LRN
LRN
Q3 26
Q4 25
6.7%
14.5%
Q3 25
17.2%
-31.6%
Q2 25
20.4%
45.6%
Q1 25
0.1%
8.6%
Q4 24
4.9%
38.0%
Q3 24
11.2%
-25.9%
Q2 24
15.3%
32.1%
Capex Intensity
CBT
CBT
LRN
LRN
Q3 26
Q4 25
8.1%
0.0%
Q3 25
7.1%
0.0%
Q2 25
6.6%
0.1%
Q1 25
7.7%
0.0%
Q4 24
8.1%
0.1%
Q3 24
9.2%
0.1%
Q2 24
5.1%
0.1%
Cash Conversion
CBT
CBT
LRN
LRN
Q3 26
1.32×
Q4 25
1.73×
0.92×
Q3 25
5.09×
-2.85×
Q2 25
2.47×
5.81×
Q1 25
0.78×
0.53×
Q4 24
1.33×
2.32×
Q3 24
1.49×
-3.47×
Q2 24
1.90×
2.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

LRN
LRN

General Education$357.5M57%
Middle - High School$259.5M41%
Adult$12.9M2%

Related Comparisons